PRKN and Hepatic fibrosis: Three promising autophagy-associated differentially expressed genes as therapeutic biomarkers for hepatic fibrosis, including autophagy - related 5 (ATG5), retinoblastoma inducible coiled-coil protein 1 (RB1CC1) and PARK2, among which RB1CC1 may promote the progression of liver fibrosis by regulating macrophages, Th17 cells, NK cells and CD56dim natural killer cells (Huang et al., 2024).